Archetype MedTech provides product development leadership to founders building physical medical devices and surgical instruments.

The work focuses on the stage where product development decisions start to carry real downstream consequence — when progress is still being made, but earlier choices begin to interact, trade-offs multiply, and fixing things later becomes expensive.

At this point, product definition, development strategy, evidence, regulatory expectations, and manufacturing reality can no longer be treated in isolation. Decisions made in one area start to constrain others, and confidence in the next step becomes as important as momentum.

Archetype MedTech works end to end across product development, leading decision-making from early product definition through regulatory readiness, manufacturing transfer, and launch. The emphasis is on identifying where complexity is building, which decisions now matter most, and what must be addressed to protect timeline, cost, and regulatory credibility.

Engagements often begin by establishing a clear, decision-ready view of the product development pathway. Where decisions continue to interact over time, this extends into longer-term product development leadership to maintain continuity of judgement through critical phases of development.

Archetype MedTech works with founder-led MedTech companies operating in, or targeting, the UK, US, and Australian markets — particularly export-first teams approaching regulatory, evidence, or manufacturing inflection points where earlier decisions are about to be locked in or audited.

Archetype MedTech

Org chart

Teams

Offices